BPC-157 Heals Muscle Crush Injury in Rats

BPC-157 effectively treated muscle crush injury in rats, improving functional recovery and histological healing of severely damaged muscle tissue — another critical injury type added to BPC-157's healing portfolio.

Novinscak, Tomislav et al.·Surgery today·2008·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01394Animal StudyPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

BPC-157 accelerated healing of muscle crush injury in rats with improved functional recovery and histological regeneration, demonstrating efficacy for acute traumatic muscle damage — expanding its musculoskeletal healing applications beyond tendon and clean transection injuries.

Key Numbers

How They Did This

animal-study study.

Why This Research Matters

Relevant for bpc-157, muscle-recovery, wound-healing.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding BPC-157 accelerated healing of muscle crush injury in rats with improved functional recovery and histological regeneration, demonstrating efficacy for
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2008.
Original Title:
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.
Published In:
Surgery today, 38(8), 716-25 (2008)
Database ID:
RPEP-01394

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

BPC-157 Heals Muscle Crush Injury in Rats

What was found?

BPC-157 effectively treated muscle crush injury in rats, improving functional recovery and histological healing of severely damaged muscle tissue — another critical injury type added to BPC-157's healing portfolio.

Read More on RethinkPeptides

Cite This Study

RPEP-01394·https://rethinkpeptides.com/research/RPEP-01394

APA

Novinscak, Tomislav; Brcic, Luka; Staresinic, Mario; Jukic, Ivana; Radic, Bozo; Pevec, Danira; Mise, Sandro; Tomasovic, Sanja; Brcic, Iva; Banic, Tihomir; Jakir, Ana; Buljat, Gojko; Anic, Tomislav; Zoricic, Ivan; Romic, Zeljko; Seiwerth, Sven; Sikiric, Predrag. (2008). Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.. Surgery today, 38(8), 716-25. https://doi.org/10.1007/s00595-007-3706-2

MLA

Novinscak, Tomislav, et al. "Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.." Surgery today, 2008. https://doi.org/10.1007/s00595-007-3706-2

RethinkPeptides

RethinkPeptides Research Database. "Gastric pentadecapeptide BPC 157 as an effective therapy for..." RPEP-01394. Retrieved from https://rethinkpeptides.com/research/novinscak-2008-gastric-pentadecapeptide-bpc-157

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.